These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7049439)

  • 21. Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.
    Block MB; Rosenfield RL; Mako ME; Steiner DF; Rubenstein AH
    N Engl J Med; 1973 May; 288(22):1144-8. PubMed ID: 4633551
    [No Abstract]   [Full Text] [Related]  

  • 22. [The possible role of adipose tissue in insulin resistance and in the physiopathology of obese diabetics].
    Guy-Grand B; Bour H
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):81-92. PubMed ID: 4606004
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.
    Madsbad S
    Diabetologia; 1983 Mar; 24(3):141-7. PubMed ID: 6341142
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucose utilization during exercise in normal and diabetic subjects. The role of insulin.
    Krzentowski G; Pirnay F; Pallikarakis N; Luyckx AS; Lacroix M; Mosora F; Lefèbvre PJ
    Diabetes; 1981 Dec; 30(12):983-9. PubMed ID: 7030833
    [No Abstract]   [Full Text] [Related]  

  • 25. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.
    Zhang CY; Baffy G; Perret P; Krauss S; Peroni O; Grujic D; Hagen T; Vidal-Puig AJ; Boss O; Kim YB; Zheng XX; Wheeler MB; Shulman GI; Chan CB; Lowell BB
    Cell; 2001 Jun; 105(6):745-55. PubMed ID: 11440717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcitonin in diabetes.
    Giugliano D; Passariello N; Sgambato S; D'Onofrio F
    Lancet; 1980 Mar; 1(8169):653. PubMed ID: 6102655
    [No Abstract]   [Full Text] [Related]  

  • 27. Aspects of continuous subcutaneous insulin infusion (CSII) in diabetes.
    Keen H; Pickup JC; Viberti GC; Bilous R; Williams G
    Diabetes Care; 1981; 4(1):54-7. PubMed ID: 7009115
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta cells and glucose in diabetes.
    Nutr Rev; 1973 Jan; 31(1):8-10. PubMed ID: 4571257
    [No Abstract]   [Full Text] [Related]  

  • 29. The pathogenesis of non-insulin-dependent diabetes: an update.
    DeFronzo RA; Ferrannini E
    Medicine (Baltimore); 1982 May; 61(3):125-40. PubMed ID: 7043155
    [No Abstract]   [Full Text] [Related]  

  • 30. [Quantitative and qualitative analysis of disorders of insulin-secretion in diabetic syndromes].
    Ellorhaoui M; Verlohren HJ
    Tunis Med; 1984 Dec; 62(8):615-8. PubMed ID: 6397884
    [No Abstract]   [Full Text] [Related]  

  • 31. [The principles of the treatment of pancreatic diabetes].
    Iván G
    Orv Hetil; 2009 Feb; 150(6):273-6. PubMed ID: 19179260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretion of glycated insulin from pancreatic beta-cells in diabetes represents a novel aspect of beta-cell dysfunction and glucose toxicity.
    McKillop AM; Abdel-Wahab YH; Mooney MH; O'Harte FP; Flatt PR
    Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S61-9; discussion 3S108-12. PubMed ID: 12688635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New horizons in our knowledge of diabetes mellitus.
    Levine R
    J Am Geriatr Soc; 1971 Nov; 19(11):897-908. PubMed ID: 4949263
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of insulin withdrawal on intermediary metabolism in patients with diabetes secondary to chronic pancreatitis.
    Larsen S; Hilsted J; Philipsen EK; Tronier B; Damkjaer Nielsen M; Worning H
    Acta Endocrinol (Copenh); 1991 May; 124(5):510-5. PubMed ID: 2028708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of islet-cell function in man.
    Arky RA; Knopp RH
    N Engl J Med; 1971 Nov; 285(20):1130-1. PubMed ID: 4937863
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects.
    Prince RL; Larkins RG; Alford FP
    Metabolism; 1981 Mar; 30(3):293-8. PubMed ID: 7010074
    [No Abstract]   [Full Text] [Related]  

  • 37. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 38. Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus.
    Buschard K; Madsbad S; Krarup T; Rygaard J
    Clin Exp Immunol; 1982 Apr; 48(1):189-95. PubMed ID: 7044628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin and metabolism: forecast of trends in research.
    Isr J Med Sci; 1972 Jun; 8(6):725-39. PubMed ID: 4559412
    [No Abstract]   [Full Text] [Related]  

  • 40. [Secretory potentialities of beta cells at early stages of diabetes mellitus].
    Ruiatkina LA; Dikker VE; Galenok VA
    Med Radiol (Mosk); 1986 Feb; 31(2):81-4. PubMed ID: 3512952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.